Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs

NCT04924803 is registered in ClinicalTrials.gov with NDRI-USA, Inc. as lead sponsor.

NCT NCT04924803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04924803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs
Lead sponsor
NDRI-USA, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 21, 2022
Completion date
February 27, 2026
Enrollment
545 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19